[Immunotherapy of head and neck cancer. Current developments].

about

[Immunotherapy of head and neck cancer. Current developments].

Item

http://www.wikidata.org/entity/Q45770749

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Immunotherapy of head and neck cancer. Current developments].

@en

[Immunotherapy of head and neck cancer. Current developments].

@nl

type

Item

label

[Immunotherapy of head and neck cancer. Current developments].

@en

[Immunotherapy of head and neck cancer. Current developments].

@nl

prefLabel

[Immunotherapy of head and neck cancer. Current developments].

@en

[Immunotherapy of head and neck cancer. Current developments].

@nl

P1476

[Immunotherapy of head and neck cancer. Current developments].

@en

P2093

C Bergmann

http://www.w3.org/2001/XMLSchema#string

P J Schuler

http://www.w3.org/2001/XMLSchema#string

S Brandau

http://www.w3.org/2001/XMLSchema#string

S Lang

http://www.w3.org/2001/XMLSchema#string

T C Gauler

http://www.w3.org/2001/XMLSchema#string

T K Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

The role of HPV in head and neck cancer and review of the HPV vaccine

A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Antibody-targeted radiation cancer therapy

A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

P2888

s00106-012-2635-6

P304

559-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00106-012-2635-6

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048379820

http://www.w3.org/2001/XMLSchema#string

P698

23247754

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy